Redmile Group, LLC

13F Holdings History for ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

Symbol: ALXO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 4.64M shares
Security Ownership: 8.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Redmile Group, LLC ownership in ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO)

2025-08-14 - Redmile Group, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.64M shares of ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO). This represents 8.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Redmile Group, LLC	8.5%		$4.78M	4.64M			$1.03	13G/A	6/30/2025	14 Aug 2025 16:17:11

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.15%	-0.01%	$1.41M	3.39M	-249,379	-6.85%	$0.42	Q2 2025
3/31/2025	0.21%	0%	$2.27M	3.64M	-48,777		$0.62	Q1 2025
12/31/2024	0.43%	-0.02%	$6.16M	3.69M	-146,965	-3.83%	$1.67	Q4 2024
9/30/2024	0.41%	-0.02%	$6.98M	3.84M	-199,875	-4.95%	$1.82	Q3 2024
6/30/2024	1.47%	-0.06%	$24.3M	4.04M	-290,058	-6.7%	$6.03	Q2 2024
3/31/2024	1.77%	+0.27%	$48.2M	4.33M	+667,245	+18.2%	$11.15	Q1 2024
12/31/2023	1.95%	+1.69%	$54.5M	3.66M	+2,375,975	+185%	$14.89	Q4 2023
9/30/2023	0.29%		$6.16M	1.28M			$4.80	Q3 2023
6/30/2023	0.37%	+0.2%	$9.64M	1.28M	+696,312	+119%	$7.51	Q2 2023
3/31/2023	0.12%	0%	$2.65M	587K	-20,493	-3.37%	$4.52	Q1 2023
12/31/2022	0.28%	-0.07%	$6.85M	607K	-144,627	-19.2%	$11.27	Q4 2022
9/30/2022	0.28%	-0.01%	$7.2M	752K	-14,700	-1.92%	$9.57	Q3 2022
6/30/2022	0.24%	0%	$6.2M	767K	-5,600	-0.73%	$8.09	Q2 2022
3/31/2022	0.41%	-0.01%	$13.1M	772K	-9,700	-1.24%	$16.90	Q1 2022
12/31/2021	0.38%	-0.04%	$16.8M	782K	-82,338	-9.53%	$21.49	Q4 2021
9/30/2021	1.11%	-0.05%	$63.8M	864K	-49,600	-5.43%	$73.86	Q3 2021
6/30/2021	0.74%	-0.05%	$50M	914K	-64,565	-6.6%	$54.68	Q2 2021
3/31/2021	1.02%	+0.02%	$72.2M	979K	+18,200	+1.9%	$73.74	Q1 2021
12/31/2020	1%	+0.58%	$82.8M	960K	+553,000	+136%	$86.20	Q4 2020
9/30/2020	0.28%	+0.28%	$15.4M	407K	+407,400	NEW	$37.74	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.